Identification of HIBCH Gene Mutations Causing Autosomal Recessive Leigh Syndrome: A Gene Involved in Valine Metabolism - 19/02/15
, Gregory M. Enns, MB, ChB b, Mary Kay Koenig, MD c, Heather Saavedra, RD, LD a, Eliana Bonfante-Mejia, MD d, Hope Northrup, MD aAbstract |
Background |
Leigh syndrome is a progressive neurodegenerative disorder with usual onset of symptoms during the first year of life. The disorder has been associated with mutations in over 30 genes. This difficulty with genetic heterogeneity makes whole exome sequencing a more cost-effective approach for investigation of etiology.
Patient and Results |
We describe an individual with typical Leigh syndrome who was found to have compound heterozygous mutations in the gene HIBCH (3-hydroxyisobutyryl coenzyme A hydrolase), an enzyme involved in the catabolism of valine. She exhibited significant clinical improvement after a valine-restricted diet.
Conclusions |
A subset of patients with uncharacterized Leigh syndrome present with specific biochemical abnormalities. This report highpoints the challenges and restrictions of routine metabolic testing and features the recognition of inborn errors of metabolism as potential treatable causes of Leigh syndrome.
Le texte complet de cet article est disponible en PDF.Keywords : Leigh syndrome, valine, inborn error of metabolism, HIBCH, whole exome sequencing
Plan
Vol 52 - N° 3
P. 361-365 - mars 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
